18th February 2020
Vital Signs Solutions a Medtech startup, closed seed investment with the help of angel investors Rod Bulmer and Gary Shuckford from Leeds-based investment connector NorthInvest.
WHAT PROBLEM IS POCDOC SOLVING?
Vital Signs Solutions closed their seed investment round for PocDoc, a mobile-based medical device that utilises technology for a real-time results analysis of “Lifestyle Diseases”, including Cardiovascular Disease and Type II Diabetes, risk factors. Developed with the aim of giving individuals a cost-effective solution to gaining control over their physical health, PocDoc combines a smartphone app and physical test chip that measures a number of key biomarkers to clinical grade from a single drop of blood.
WHAT WAS THE FUNDING USED FOR?
Steve Roest, Co-Founder of Vital Signs Solutions, said:
‘With over 280 million individuals at risk of developing a Lifestyle Disease in UK, US, Germany, France, Italy and Spain, and Type II Diabetes alone costing the UK tax payer £20 billion per year, it’s clear that there is an urgent need for cost-effective, easily-accessible solutions for individuals to understand risks in their lifestyle that could lead to health problems. We’re very excited to work with Rod Bulmer and Gary Shuckford to help us achieve our mission and help save lives.’
Vital Signs Solutions is the third MedTech start-up to be supported by angel investors at NorthInvest in the not-for-profit investment organisation’s first year of operations, following investments in MedCircuit and Renephra in 2018.
Gary Shuckford, Angel Investor at NorthInvest and Director of Edenbridge Healthcare, said:
‘Vital Signs Solutions and their technology, PocDoc helps deliver innovative point of care testing for common blood tests and has the potential to make a significant difference to patients lives and reduce NHS costs.’
Rod Bulmer, Angel Investor at NorthInvest, said:
‘I’m delighted to support Vital Signs Solutions and believe PocDoc has the potential to help individuals develop a keen understanding of their own health to prevent problems down the line, and ultimately relieve the strain on our already under-funded National Health Service. I look forward to working with Vital Signs Solutions on this venture.’
Founding Board Director at NorthInvest, Helen Oldham, said:
‘Vital Signs Solutions is yet another example of the great capacity in the North to nurture medtech innovations. We’re delighted we can continue to support ambitious entrepreneurs through our community of angel investors, many of which are experienced in the healthcare and medtech sectors.’